The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...

Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...

Bravecto Plus Topical for Cats is a liquid that you apply to your cat’s skin between the shoulder blades every 8 weeks. Bravecto Plus Topical for Cats provides protection against fleas, ticks ...

BRAVECTO PLUS for Cats is for cats 6 months of age or older. Side effects may include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation.

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug ...